Cited by 2,461Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatmentsGeriatric Care and Nursing Homes

The DOI matches its Crossref record; 495 of the 496 references it cites were found in a registry or an index.

2019 Alzheimer’s disease facts and figures.

Alzheimer's Association·2019·Alzheimer's & Dementia

DOI 10.1016/j.jalz.2019.01.010

Open this paper in CoChat — free account

Abstract

This article describes the public health impact of Alzheimer's disease (AD), including incidence and prevalence, mortality and morbidity, use and costs of care, and the overall impact on caregivers and society. The Special Report examines the use of brief cognitive assessments by primary care physicians as a tool for improving early detection of dementia. An estimated 5.8 million Americans have Alzheimer's dementia. By mid‐century, the number of people living with Alzheimer's dementia in the United States may grow to 13.8 million, fueled in large part by the aging baby boom generation. In 2017, official death certificates recorded 121,404 deaths from AD, making AD the sixth leading cause of death in the United States and the fifth leading cause of death among Americans age ≥65 years. Between 2000 and 2017, deaths resulting from stroke, heart disease, and prostate cancer decreased, whereas reported deaths from AD increased 145%. In 2018, more than 16 million family members and other unpaid caregivers provided an estimated 18.5 billion hours of care to people with Alzheimer's or other dementias. This care is valued at nearly $234 billion, but its costs extend to family caregivers' increased risk for emotional distress and negative mental and physical health outcomes. Average per‐person Medicare payments for services to beneficiaries age ≥65 years with Alzheimer's or other dementias are more than three times as great as payments for beneficiaries without these conditions. Total payments in 2019 for health care, long‐term care and hospice services for people age ≥65 years with dementia are estimated to be $290 billion. Early detection of Alzheimer's offers numerous medical, emotional and financial benefits—benefits that accrue to affected individuals and their families as well as to society at large. Alzheimer's Association surveys regarding brief cognitive assessments for detection of dementia found that while a large majority of seniors and primary care physicians say the assessments are important, only half of seniors have received an assessment, and only 16 percent of seniors receive regular cognitive assessments. Many educational opportunities exist to facilitate increased use of brief cognitive assessments in the primary care setting.

Integrity signals

Registry

Crossref · 10.1016/j.jalz.2019.01.010

Cites

495 of 495 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R., Kawas, C. H., Klunk, W. E., Koroshetz, W. J., Manly, J. J., Mayeux, R., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.005 · Cited by 18,657
ASSESSMENT OF COMA AND IMPAIRED CONSCIOUSNESS
Teasdale, G., & Jennett, B. (1974) · The Lancet · doi:10.1016/s0140-6736(74)91639-0 · Cited by 13,215
Prevalence, Severity, and Comorbidity of 12-Month DSM-IV Disorders in the National Comorbidity Survey Replication
Kessler, R. C., Chiu, W. T., Demler, O., & Walters, E. E. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.6.617 · Cited by 12,052
The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Albert, M. S., DeKosky, S. T., Dickson, D., Dubois, B., Feldman, H. H., Fox, N. C., Gamst, A., Holtzman, D. M., Jagust, W. J., Petersen, R. C., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.008 · Cited by 10,152
Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease
Sperling, R. A., Aisen, P. S., Beckett, L. A., Bennett, D. A., Craft, S., Fagan, A. M., Iwatsubo, T., Jack, C. R., Kaye, J., Montine, T. J., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.003 · Cited by 7,155
Dementia prevention, intervention, and care
Livingston, G., Sommerlad, A., Orgeta, V., Costafreda, S. G., Huntley, J., Ames, D., Ballard, C., Banerjee, S., Burns, A., Cohen-Mansfield, J., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31363-6 · Cited by 6,072
International Statistical Classification of Diseases and Related Health Problems
(2010) · Springer eBooks · doi:10.1007/978-0-387-79948-3_3055 · Cited by 4,182
What is cognitive reserve? Theory and research application of the reserve concept
STERN, Y. (2002) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617702813248 · Cited by 3,951
Clinical and biomarker changes in dominantly inherited Alzheimer's disease
Bateman, R. J., Xiong, C., Benzinger, T. L. S., Fagan, A. M., Goate, A., Fox, N. C., Marcus, D. S., Cairns, N. J., Xie, X., Blazey, T. M., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1202753 · Cited by 3,814
Association of apolipoprotein E allele ϵ4 with late‐onset familial and sporadic Alzheimer's disease
Saunders, A. M., Strittmatter, W. J., Schmechel, D., St. George-Hyslop, P. H., Pericak-Vance, M. A., Joo, S. H., Rosi, B. L., Gusella, J. F., Crapper-MacLachlan, D. R., Alberts, M. J., et al. (1993) · Neurology · doi:10.1212/wnl.43.8.1467 · Cited by 3,786

Show all 496 references

Research works printed but not linked: 26

Grossberg GT, 2010, The art of sharing the diagnosis and management of Alzheimer's disease with patients and caregivers: Recommendations of an expert consensus panel, Prim Care Companion J Clin Psychiatry, 12
2015, Cognitive Aging: Progress in Understanding and Opportunity for Action
Sajeev G, Diabetes. The AlzRisk Database. Alzheimer Research Forum
Steptoe A, 2005, Aging, Health, and Public Policy
He W, 2016, International Population Reports, P95/16‐1, An Aging World: 2015
2006, Early‐Onset Dementia: A National Challenge, a Future Crisis
Manly JJ, 2004, Critical perspectives on racial and ethnic differentials in health in late life, 95
Prince MJ, 2015, World Alzheimer Report 2015: The Global Impact of Dementia: An Analysis of Prevalence
Ortman JM, 2014, An Aging Nation: The Older Population in the United States, Current Population Reports, P25‐1140
Heron M, 2018, Deaths: Leading causes for 2016
Kasper JD, 2014, Disability and Care Needs of Older Americans by Dementia Status: An Analysis of the 2011 National Health and Aging Trends Study
Maslow K, 2012, Translating Innovation to Impact: Evidence‐Based Interventions to Support People with Alzheimer's Disease and their Caregiver at Home and in the Community
Zarit SH, 2009, Aging families and caregiving, 131
Whitlatch CJ, 2018, Meeting the informational, educational, and psychosocial support needs of persons living with dementia and their family caregivers, Gerontologist, 58, S58
Khatutsky G, 2011, Understanding direct care workers: A snapshot of two of America's most important jobs: Certified nursing assistants and home health aides
Stone R, 2012, Universal Coverage of Long‐Term Care in the United States: Can We Get There from Here?, 155
Eldercare Workforce Alliance, 2012, Geriatrics Workforce Shortage: A Looming Crisis for our Families
National Academies of Sciences, 2016, Engineering, and Medicine. Families Caring for an Aging America
Eiken S, 2018, Medicaid Expenditures for Long‐Term Services and Supports in FY 2016. IAP Medicaid Innovation Accelerator Program
Bynum J, 2009, Unpublished; provided under contract with the Alzheimer's Association
Jacobson G, 2017, Income and Assets of Medicare Beneficiaries, 2016‐2035
National Association of Insurance Commissioners and the Center for Insurance Policy and Research, 2016, The State of Long‐Term Care Insurance: The Market, Challenges and Future Innovations
Reaves EL, 2015, Medicaid and Long‐Term Services and Supports: A Primer
10.1111/j.1525-1497.2005.0126.x · DOI
Albert SM, 2010, The MetLife Study of working caregivers and employer health care costs
Shriver M, 2010, The Shriver Report: A Woman's Nation Takes on Alzheimer's

Sorted by citations

Items 401–500 of 1,019

The Association of Osteoarthritis and Related Pain Burden to Incident Alzheimer’s Disease and Related Dementias: A Retrospective Cohort Study of U.S. Medicare Beneficiaries
Innes, K. E., & Sambamoorthi, U. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-191311 · Cited by 47
Status and future directions of clinical trials in Alzheimer's disease
Plascencia‐Villa, G., & Perry, G. L. (2020) · International review of neurobiology · doi:10.1016/bs.irn.2020.03.022 · Cited by 49
One-carbon epigenetics and redox biology of neurodegeneration
Coppedè, F. (2020) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.12.002 · Cited by 48
Synthesis and bio-evaluation of new multifunctional methylindolinone-1,2,3-triazole hybrids as anti-Alzheimer's agents
Saeedi, M., Maleki, A., Iraji, A., Hariri, R., Akbarzadeh, T., Edraki, N., Firuzi, O., & Mirfazli, S. S. (2020) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2020.129828 · Cited by 47
Enhancing of dataset using DeepDream, fuzzy color image enhancement and hypercolumn techniques to detection of the Alzheimer's disease stages by deep learning model
Toğaçar, M., Cömert, Z., & Ergen, B. (2021) · Neural Computing and Applications · doi:10.1007/s00521-021-05758-5 · Cited by 47
Current Cognition Tests, Potential Virtual Reality Applications, and Serious Games in Cognitive Assessment and Non-Pharmacological Therapy for Neurocognitive Disorders
Jin, R., Pilozzi, A. R., & Huang, X. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9103287 · Cited by 53
The Impact of Robotic Companion Pets on Depression and Loneliness for Older Adults with Dementia During the COVID-19 Pandemic
Fogelson, D. M., Rutledge, C., & Zimbro, K. S. (2021) · Journal of Holistic Nursing · doi:10.1177/08980101211064605 · Cited by 46
Potential Role of Glucagon-like Peptide-1 Receptor Agonists in the Treatment of Cognitive Decline and Dementia in Diabetes Mellitus
Pelle, M. C., Zaffina, I., Giofrè, F., Pujia, R., & Arturi, F. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411301 · Cited by 50
State Variability in the Prevalence and Healthcare Utilization of Assisted Living Residents with Dementia
Thomas, K. S., Zhang, W., Cornell, P. Y., Smith, L., Kaskie, B. P., & Carder, P. (2020) · Journal of the American Geriatrics Society · doi:10.1111/jgs.16410 · Cited by 46
The Role of Interleukin-33 in Patients with Mild Cognitive Impairment and Alzheimer's Disease
Liang, C., Su, K., Tsai, C., Lee, J., Chu, C., Yeh, T., Su, M., Lin, G., Lin, Y., Chu, H., et al. (2020) · Alzheimer s Research & Therapy · doi:10.1186/s13195-020-00652-z · Cited by 48
Graphene based electrochemical immunosensor for the ultra-sensitive label free detection of Alzheimer's beta amyloid peptides Aβ(1–42)
Abbasi, H. Y., Tehrani, Z., Devadoss, A., Ali, M. M., Moradi-Bachiller, S., Albani, D., & Guy, O. J. (2021) · Nanoscale Advances · doi:10.1039/d0na00801j · Cited by 46
Antagonists targeting eEF2 kinase rescue multiple aspects of pathophysiology in Alzheimer’s disease model mice
Kasica, N. P., Zhou, X., Yang, Q., Wang, X., Yang, W., Zimmermann, H. R., Holland, C. E., Koscielniak, E., Wu, H., Cox, A. O., et al. (2022) · Journal of Neurochemistry · doi:10.1111/jnc.15562 · Cited by 34
Effects of Mindfulness-Based Interventions on Depressive Symptoms, Anxiety, Stress, and Quality of Life in Family Caregivers of Persons Living with Dementia: A Systematic Review and Meta-analysis
Han, A. (2022) · Research on Aging · doi:10.1177/01640275211043486 · Cited by 45
Diverse Applications of Artificial Intelligence in Neuroradiology
Duong, M. T., Rauschecker, A. M., & Mohan, S. (2020) · Neuroimaging Clinics of North America · doi:10.1016/j.nic.2020.07.003 · Cited by 46
Joint model for survival and multivariate sparse functional data with application to a study of Alzheimer's Disease
Li, C., Xiao, L., & Luo, S. (2021) · Biometrics · doi:10.1111/biom.13427 · Cited by 45
RETRACTED ARTICLE: Potential innovation against Alzheimer’s disorder: a tricomponent combination of natural antioxidants (vitamin E, quercetin, and basil oil) and the development of its intranasal delivery
Karthika, C., Appu, A. P., Akter, R., Rahman, M. H., Tagde, P., Ashraf, G. M., Abdel‐Daim, M. M., Hassan, S. S. U., Abid, A., & BUNGAU, S. G. (2022) · Environmental Science and Pollution Research · doi:10.1007/s11356-021-17830-7 · Cited by 46
“With health care costs accounting for over a hundred and thirty billion euros per year, this group of diseases poses a significant burden to European society (Alzheimer’s Association 2019).”
Influential
Retracted
Evaluation of synthetic 2-aryl quinoxaline derivatives as α-amylase, α-glucosidase, acetylcholinesterase, and butyrylcholinesterase inhibitors
Hameed, S., Khan, K. M., Taslımı, P., Salar, U., Taşkın‐Tok, T., Kısa, D., Saleem, F., Solangi, M., Ahmed, M. H. U., & Rani, K. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.05.040 · Cited by 45
Iron in Alzheimer’s Disease: From Physiology to Disease Disabilities
Pal, A., Cerchiaro, G., Rani, I., Ventriglia, M., Rongioletti, M. C. A., Longobardi, A., & Squitti, R. (2022) · Biomolecules · doi:10.3390/biom12091248 · Cited by 49
Considerations for widespread implementation of blood‐based biomarkers of Alzheimer's disease
Mielke, M. M., Anderson, M., Ashford, J. W., Jeromin, A., Lin, P., Rosen, A. C., Tyrone, J., VandeVrede, L. A., Willis, D. R., Hansson, O., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14150 · Cited by 47
“24,25 More-over,evenwhenoffered,manypatientsdeclinecognitivetestingdueto stigma or other concerns.”
‘Walk a mile in my shoes:’ African American caregiver perceptions of caregiving and self-care
Cothran, F. A., Paun, O., Strayhorn, S. M., & Barnes, L. L. (2020) · Ethnicity and Health · doi:10.1080/13557858.2020.1734777 · Cited by 54
Defining and predicting transdiagnostic categories of neurodegenerative disease
Cornblath, E. J., Robinson, J. L., Irwin, D. J., Lee, E. B., Lee, V. M. ‐., Trojanowski, J. Q., & Bassett, D. S. (2020) · Nature Biomedical Engineering · doi:10.1038/s41551-020-0593-y · Cited by 48
Porphyromonas Gingivalis as a Risk Factor to Alzheimer’s Disease: A Systematic Review
Elwishahy, A., Antia, K., Bhusari, S., Ilechukwu, C., Horstick, O., & Winkler, V. F. (2021) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-200237 · Cited by 48
Detection of Mild Cognitive Impairment in an At-Risk Group of Older Adults: Can a Novel Self-Administered Serious Game-Based Screening Test Improve Diagnostic Accuracy?
Zygouris, S., Iliadou, P., Lazarou, E., Giakoumis, D., Votis, K., Alexiadis, A., Triantafyllidis, A. K., Segkouli, S., Tzovaras, D. K., Tsiatsos, Τ., et al. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200880 · Cited by 44
Large‐scale proteome and metabolome analysis of CSF implicates altered glucose and carbon metabolism and succinylcarnitine in Alzheimer's disease
Panyard, D. J., McKetney, J., Deming, Y. K., Morrow, A. R., Ennis, G. E., Jonaitis, E. M., Hulle, C. A. V., Yang, C., Sung, Y. J., Ali, M., et al. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13130 · Cited by 48
Bilingualism for delaying the onset of Alzheimer’s disease: a systematic review and meta-analysis
Paulavicius, A., Mizzaci, C. C., Tavares, D. R. B., da Rocha, A. P., Civile, V. T., Schultz, R. R., Pinto, A. C. P. N., & Trevisani, V. F. M. (2020) · European Geriatric Medicine · doi:10.1007/s41999-020-00326-x · Cited by 44
Effects of sex, race, ethnicity, and education on online aging research participation
Ashford, M. T., Eichenbaum, J., Williams, T., Camacho, M. R., Fockler, J., Ulbricht, A., Flenniken, D., Truran, D., Mackin, R. S., Weiner, M. W., et al. (2020) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.12028 · Cited by 44
Exercise training improves vascular function in patients with Alzheimer’s disease
Pedrinolla, A., Venturelli, M., Fonte, C., Tamburin, S., Baldassarre, A. D., Naro, F., Varalta, V., Giuriato, G., Ghinassi, B., Muti, E., et al. (2020) · European Journal of Applied Physiology · doi:10.1007/s00421-020-04447-w · Cited by 44
Sex differences in dementia: on the potentially mediating effects of educational attainment and experiences of psychological distress
Hasselgren, C., Ekbrand, H., Halleröd, B., Fässberg, M. M., Zettergren, A., Johansson, L. H., Skoog, I. G., & Dellve, L. (2020) · BMC Psychiatry · doi:10.1186/s12888-020-02820-9 · Cited by 46
Mercury and Alzheimer’s disease: a look at the links and evidence
Azar, J., Yousef, M. H., El‐Fawal, H. A. N., & Abdelnaser, A. (2021) · Metabolic Brain Disease · doi:10.1007/s11011-020-00649-5 · Cited by 46
Serotonin and Melatonin Show Different Modes of Action on Aβ42 Protofibril Destabilization
Gong, Y., Zhan, C., Zou, Y. F., Qian, Z., Wei, G., & Zhang, Q. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.1c00038 · Cited by 46
Screening for Early-Stage Alzheimer’s Disease Using Optimized Feature Sets and Machine Learning
Kleiman, M. J., Barenholtz, E., Galvin, J. E., & Initiative, F. T. A. D. N. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-201377 · Cited by 42
Stem Cells: Innovative Therapeutic Options for Neurodegenerative Diseases?
Bonaventura, G., Munafò, A., Bellanca, C. M., Cognata, V. L., Iemmolo, R., Attaguile, G. A., Mauro, R. D., Benedetto, G. D., Cantarella, G., Barcellona, M. L., et al. (2021) · Cells · doi:10.3390/cells10081992 · Cited by 44
Inter-individual differences in the responses to aerobic exercise in Alzheimer’s disease: Findings from the FIT-AD trial
Yu, F., Salisbury, D., & Mathiason, M. A. (2021) · Journal of Sport and Health Science · doi:10.1016/j.jshs.2020.05.007 · Cited by 40
The effect of aged microglia on synaptic impairment and its relevance in neurodegenerative diseases
Triviño, J. J., & von Bernhardi, R. (2021) · Neurochemistry International · doi:10.1016/j.neuint.2021.104982 · Cited by 43
Crossing the “Cookie Theft” Corpus Chasm: Applying What BERT Learns From Outside Data to the ADReSS Challenge Dementia Detection Task
Guo, Y., Li, C., Roan, C., Pakhomov, S., & Cohen, T. (2021) · Frontiers in Computer Science · doi:10.3389/fcomp.2021.642517 · Cited by 44
Volumetry of Olfactory Structures in Mild Cognitive Impairment and Alzheimer’s Disease: A Systematic Review and a Meta-Analysis
Jobin, B., Boller, B., & Frasnelli, J. (2021) · Brain Sciences · doi:10.3390/brainsci11081010 · Cited by 43
Effectiveness of Dance-Based Interventions on Depression for Persons With MCI and Dementia: A Systematic Review and Meta-Analysis
Wang, Y., Liu, M., Tan, Y., Dong, Z., Wu, J., Cui, H., Shen, D., & Chi, I. (2022) · Frontiers in Psychology · doi:10.3389/fpsyg.2021.709208 · Cited by 43
Psychometric properties of the Alzheimer’s Disease Cooperative Study – Activities of Daily Living for Mild Cognitive Impairment (ADCS-MCI-ADL) scale: a post hoc analysis of the ADCS ADC-008 trial
Potashman, M. H., Pang, M., Tahir, M. J., Shahraz, S., Dichter, S., Perneczky, R., & Nolte, S. (2023) · BMC Geriatrics · doi:10.1186/s12877-022-03527-0 · Cited by 44
Microbiota-Gut-Brain Axis Dysregulation in Alzheimer's Disease: Multi-Pathway Effects and Therapeutic Potential
Qu, L., Li, Y., Liu, F., Fang, Y., He, J., Ma, J., Xu, T., Wang, L., Lei, P., Dong, H., et al. (2023) · Aging and Disease · doi:10.14336/ad.2023.0823-2 · Cited by 46
Design, Synthesis, and In Vitro Evaluation of Hydroxybenzimidazole-Donepezil Analogues as Multitarget-Directed Ligands for the Treatment of Alzheimer’s Disease
Chaves, S., Resta, S., Rinaldo, F., Costa, M., Josselin, R., Gwizdała, K., Piemontese, L., Capriati, V., Pereira-Santos, A. R., Cardoso, S. M., et al. (2020) · Molecules · doi:10.3390/molecules25040985 · Cited by 42
Management of cognitive decline in Alzheimer's disease using a non-pharmacological intervention program
Quail, Z., Carter, M. M., Wei, A., & Li, X. (2020) · Medicine · doi:10.1097/md.0000000000020128 · Cited by 43
Mechanistic insight into the role of metformin in Alzheimer's disease
Sanati, M., Aminyavari, S., Afshari, A. R., & Sahebkar, A. (2022) · Life Sciences · doi:10.1016/j.lfs.2021.120299 · Cited by 44
Emerging Roles of Microfluidics in Brain Research: From Cerebral Fluids Manipulation to Brain-on-a-Chip and Neuroelectronic Devices Engineering
Wan, J., Zhou, S., Mea, H. J., Guo, Y., Ku, H., & Urbina, B. (2022) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00480 · Cited by 45
The relationship between Alzheimer’s disease and intestinal microflora structure and inflammatory factors
Wang, S.-S., Li, X., Liu, P., Li, J., & Liu, L. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.972982 · Cited by 42
DecGAN: Decoupling Generative Adversarial Network for Detecting Abnormal Neural Circuits in Alzheimer's Disease
Pan, J., Zuo, Q., Wang, B.-C., Chen, C. L. P., Lei, B., & Wang, S. (2024) · IEEE Transactions on Artificial Intelligence · doi:10.1109/tai.2024.3416420 · Cited by 56
Aggregation Mechanisms and Molecular Structures of Amyloid‐β in Alzheimer's Disease
Niu, Z., Gui, X., Feng, S., & Reif, B. (2024) · Chemistry - A European Journal · doi:10.1002/chem.202400277 · Cited by 46
A novel graph neural network method for Alzheimer’s disease classification
Zhou, Z., Wang, Q., An, X., Chen, S., Sun, Y., Wang, G., & Yan, G. (2024) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2024.108869 · Cited by 45
Systems Pharmacology Approach to Investigate the Mechanism of Kai-Xin-San in Alzheimer’s Disease
Luo, Y., Li, D., Liao, Y., Cai, C., Wu, Q., Ke, H., Liu, X., Li, H.-L., Hong, H., Xu, Y., et al. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00381 · Cited by 43
The Residential Care Transition Module: a single-blinded randomized controlled evaluation of a telehealth support intervention for family caregivers of persons with dementia living in residential long-term care
Gaugler, J. E., Statz, T. L., Birkeland, R. W., Louwagie, K. W., Peterson, C., Zmora, R., Emery, A., McCarron, H. R., Hepburn, K. W., Whitlatch, C. J., et al. (2020) · BMC Geriatrics · doi:10.1186/s12877-020-01542-7 · Cited by 43
Machine Learning for the Classification of Alzheimer’s Disease and Its Prodromal Stage Using Brain Diffusion Tensor Imaging Data: A Systematic Review
Billeci, L., Badolato, A., Bachi, L., & Tonacci, A. (2020) · Processes · doi:10.3390/pr8091071 · Cited by 44
Longitudinal Speech Biomarkers for Automated Alzheimer's Detection
Laguarta, J., Hueto, F., Rajasekaran, P., Sarma, S. E., & Subirana, B. (2021) · Frontiers in Computer Science · doi:10.3389/fcomp.2021.624694 · Cited by 50
Knowledge and perceptions of Alzheimer’s disease in three ethnic groups of younger adults in the United Kingdom
Kafadar, A. H., Barrett, C., & Cheung, K. L. (2021) · BMC Public Health · doi:10.1186/s12889-021-11231-8 · Cited by 46
The use of proxies and proxy-reported measures: a report of the international society for quality of life research (ISOQOL) proxy task force
Roydhouse, J. K., Cohen, M. L., Eshoj, H. R., Corsini, N., Yücel, E., Rutherford, C., Wac, K., Berrocal, A., Lanzi, A. M., Nowinski, C. J., et al. (2021) · Quality of Life Research · doi:10.1007/s11136-021-02937-8 · Cited by 42
Further SAR studies on natural template based neuroprotective molecules for the treatment of Alzheimer’s disease
Singh, Y. P., Shankar, G., Jahan, S., Singh, G., Kumar, N., Barik, A., Upadhyay, P., Singh, L., Kamble, K., Singh, G. K., et al. (2021) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2021.116385 · Cited by 42
Acupuncture enhances brain function in patients with mild cognitive impairment: evidence from a functional-near infrared spectroscopy study
Hong, K., Khan, M. N. A., Ghafoor, U., & Yoo, H.-R. (2021) · Neural Regeneration Research · doi:10.4103/1673-5374.332150 · Cited by 42
Feasibility of Using a Wearable Biosensor Device in Patients at Risk for Alzheimer's Disease Dementia
Saif, N., Yan, P., Niotis, K., Scheyer, O., Rahman, A., Berkowitz, M., Krikorian, R., Hristov, H., Sadek, G., Bellara, S., et al. (2020) · The Journal of Prevention of Alzheimer's Disease · doi:10.14283/jpad.2019.39 · Cited by 41
Signature Effects of Vector-Guided Systemic Nano Bioconjugate Delivery Across Blood-Brain Barrier of Normal, Alzheimer’s, and Tumor Mouse Models
Israel, L. L., Galstyan, A., Cox, A., Shatalova, E. S., Sun, T., Rashid, M.-H., Grodzinski, Z., Chiechi, A., Fuchs, D.-T., Patil, R., et al. (2022) · ACS Nano · doi:10.1021/acsnano.1c10034 · Cited by 41
Reducing variations in multi-center Alzheimer’s disease classification with convolutional adversarial autoencoder
Cobbinah, B. M., Sorg, C., Yang, Q., Ternblom, A., Zheng, C., Han, W., Che, L., & Shao, J. (2022) · Medical Image Analysis · doi:10.1016/j.media.2022.102585 · Cited by 41
“Alzheimer’s disease (AD) is characterized by increasing cognitive and behavioral impairments, eventually resulting in dementia syndrome; it is a neurodegenerative disease, which is the most common cause of age-related dementia (Jack et al., 2018; Association, 2019).”
The influence of growth and sex hormones on risk of alzheimer’s disease: a mendelian randomization study
Yeung, C. H. C., Yeung, S. L. A., Kwok, M. K., Zhao, J. V., & Schooling, C. M. (2023) · European Journal of Epidemiology · doi:10.1007/s10654-023-01015-2 · Cited by 43
A spatiotemporal graph transformer approach for Alzheimer’s disease diagnosis with rs-fMRI
He, P., Shi, Z., Cui, Y., Wang, R., & Wu, D. (2024) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2024.108762 · Cited by 41
Clinicians’ communication with patients receiving a MCI diagnosis: The ABIDE project
Visser, L. N. C., van Maurik, I. S., Bouwman, F. H., Staekenborg, S. S., Vreeswijk, R., Hempenius, L., de Beer, M. H., Roks, G., Boelaarts, L., Kleijer, M., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0227282 · Cited by 41
Neural Correlates of Verb Fluency Performance in Cognitively Healthy Older Adults and Individuals With Dementia: A Pilot fMRI Study
Paek, E. J., Murray, L. L., & Newman, S. D. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00073 · Cited by 42
Structural exploration of multifunctional monoamine oxidase B inhibitors as potential drug candidates against Alzheimer’s disease
Zhang, C., Lv, Y., Bai, R., & Xie, Y. (2021) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2021.105070 · Cited by 41
Advances in Proteasome Enhancement by Small Molecules
George, D. E., & Tepe, J. J. (2021) · Biomolecules · doi:10.3390/biom11121789 · Cited by 42
Same-Sex Couples and Cognitive Impairment: Evidence From the Health and Retirement Study
Liu, H., Hsieh, N., Zhang, Z., Zhang, Y., & Langa, K. M. (2021) · The Journals of Gerontology: Series B · doi:10.1093/geronb/gbaa202 · Cited by 40
Building clinically relevant outcomes across the Alzheimer's disease spectrum
Rentz, D. M., Wessels, A. M., Annapragada, A. V., Berger, A., Edgar, C. J., Gold, M., Miller, D. S., Randolph, C., Ryan, J. M., Wunderlich, G., et al. (2021) · Alzheimer's & Dementia: Translational Research & Clinical Interventions · doi:10.1002/trc2.12181 · Cited by 38
Amyloid-β-Derived Peptidomimetics Inhibits Tau Aggregation
Gorantla, N. V., Sunny, L. P., Rajasekhar, K., Nagaraju, P. G., G., P. P. C., Govindaraju, T., & Chinnathambi, S. (2021) · ACS Omega · doi:10.1021/acsomega.9b03497 · Cited by 40
Evaluation of cholinesterase inhibitory and antioxidant activity of Wedelia chinensis and isolation of apigenin as an active compound
Islam, M. A., Zaman, S., Biswas, K., Al-Amin, M. Y., Hasan, M. K., Alam, A. H. M. K., Tanaka, T., & Sadik, G. (2021) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-021-03373-4 · Cited by 46
Short-Term Associations between Ambient Temperature and Emergency Department Visits for Alzheimer's Disease and Related Dementia in Five Us StatesPreprint
Zhang, Y., Ebelt, S., Shi, L., Scovronick, N., D’Souza, R. R., Steenland, K., & Chang, H. H. (2022) · SSRN Electronic Journal · doi:10.1016/j.envres.2022.115176 · Cited by 42
Factor structure of the Harmonized Cognitive Assessment Protocol neuropsychological battery in the Health and Retirement Study
Jones, R. N., Manly, J. J., Langa, K. M., Ryan, L. H., Levine, D. A., McCammon, R. J., & Weir, D. R. (2023) · Journal of the International Neuropsychological Society · doi:10.1017/s135561772300019x · Cited by 42
Unraveling the Genetic Landscape of Neurological Disorders: Insights into Pathogenesis, Techniques for Variant Identification, and Therapeutic Approaches
Firdaus, Z., & Li, X. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25042320 · Cited by 46
“Currently, the disease affects one in nine people over the age of 65 and one in three people over the age of 85 [116].”
BackgroundInfluential
Pilot Test of a Computer-Based System to Help Family Caregivers of Dementia Patients
Gustafson, D. H., Gustafson, D. H., Cody, O. J., Chih, M., Johnston, D. C., & Asthana, S. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190052 · Cited by 40
The need for improved cognitive, hearing and vision assessments for older people with cognitive impairment: a qualitative study
Wolski, L., Leroi, I., Regan, J. L., Dawes, P., Charalambous, A. P., Thodi, C., Prokopiou, J., Villeneuve, R., Helmer, C., Yohannes, A. M., et al. (2019) · BMC Geriatrics · doi:10.1186/s12877-019-1336-3 · Cited by 40
Functional survival forests for multivariate longitudinal outcomes: Dynamic prediction of Alzheimer’s disease progression
Lin, J. J., Li, K., & Luo, S. (2020) · Statistical Methods in Medical Research · doi:10.1177/0962280220941532 · Cited by 40
Self‐efficacy of family caregivers of older adults with cognitive impairment: A concept analysis
Khan, T. S., Hirschman, K. B., McHugh, M. D., & Naylor, M. D. (2020) · Nursing Forum · doi:10.1111/nuf.12499 · Cited by 42
The Vagal Autonomic Pathway of COVID-19 at the Crossroad of Alzheimer’s Disease and Aging: A Review of Knowledge
Rangon, C.-M., Krantic, S. M., Moyse, E., & Fougère, B. (2020) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-200273 · Cited by 40
The effect of direct cognitive assessment in the Medicare annual wellness visit on dementia diagnosis rates
Lind, K. E., Hildreth, K. L., Lindrooth, R. C., Morrato, E. H., Crane, L. A., & Perraillon, M. C. (2021) · Health Services Research · doi:10.1111/1475-6773.13627 · Cited by 39
Religious Involvement and Cognitive Functioning at the Intersection of Race/Ethnicity and Gender in Mid-Life and Older Adults.
Henderson, A., Walsemann, K., & Ailshire, J. A. (2021) · The journals of gerontology. Series B, Psychological sciences and social sciences · doi:10.1093/geronb/gbab034 · Cited by 34
Periodontal disease and the risk of Alzheimer's disease and mild cognitive impairment: a systematic review and meta‐analysis
Hu, X. Y., Zhang, J., Qiu, Y., & Liu, Z. (2021) · Psychogeriatrics · doi:10.1111/psyg.12743 · Cited by 52
Rational design and biological evaluation of a new class of thiazolopyridyl tetrahydroacridines as cholinesterase and GSK-3 dual inhibitors for Alzheimer’s disease
Jiang, X., Zhou, J., Wang, Y., Chen, L., Duan, Y., Huang, J., Liu, C., Chen, Y., Liu, W., Sun, H., et al. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112751 · Cited by 39
Herbal Therapeutics for Alzheimer's Disease: Ancient Indian Medicine System from the Modern Viewpoint
Kushwah, S., Maurya, N. S., Kushwaha, S. K., Scotti, L., Chawade, A., & Mani, A. (2023) · Current Neuropharmacology · doi:10.2174/1570159x21666230216094353 · Cited by 42
Midlife Chronological and Endocrinological Transitions in Brain Metabolism: System Biology Basis for Increased Alzheimer’s Risk in Female Brain
Wang, Y., Shang, Y., Mishra, A., Bacon, E., Yin, F., & Brinton, R. (2020) · Scientific Reports · doi:10.1038/s41598-020-65402-5 · Cited by 42
Novel Blood-Derived Extracellular Vesicle-Based Biomarkers in Alzheimer’s Disease Identified by Proximity Extension Assay
Nielsen, J. E., Pedersen, K. S., Vestergård, K., Maltesen, R. G., Christiansen, G., Lundbye‐Christensen, S., Moos, T., Kristensen, S. R., & Pedersen, S. (2020) · Biomedicines · doi:10.3390/biomedicines8070199 · Cited by 39
Non-Invasive RF Technique for Detecting Different Stages of Alzheimer’s Disease and Imaging Beta-Amyloid Plaques and Tau Tangles in the Brain
Saied, I., Arslan, T., Chandran, S., Smith, C., Spires‐Jones, T. L., & Pal, S. (2020) · IEEE Transactions on Medical Imaging · doi:10.1109/tmi.2020.3011359 · Cited by 44
A Brief Digital Cognitive Assessment for Detection of Cognitive Impairment in Cuban Older Adults
Rodriguez‐Salgado, A. M., Llibre‐Guerra, J. J., Tsoy, E., Peñalver, A. I., Bringas, G., Erlhoff, S. J., Kramer, J. H., Allen, I. E., Valcour, V., Miller, B. L., et al. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200985 · Cited by 41
A Review of Brain Atrophy Subtypes Definition and Analysis for Alzheimer’s Disease Heterogeneity Studies
Zhang, B., Lin, L., & Wu, S. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-201274 · Cited by 40
Sex differences in brain aging among adults with family history of Alzheimer’s disease and APOE4 genetic risk
Subramaniapillai, S., Rajagopal, S., Snytte, J., Otto, A. R., Einstein, G., & Rajah, M. N. (2021) · NeuroImage Clinical · doi:10.1016/j.nicl.2021.102620 · Cited by 44
Design, synthesis, and biological evaluation of diosgenin-indole derivatives as dual-functional agents for the treatment of Alzheimer’s disease
Zhou, L., Liang, Y.-F., Huang, Y., Yang, G., Zheng, L., Sun, J., Li, Y., Zhu, F., Qian, H., Wang, R., et al. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113426 · Cited by 39
Challenges in LC–MS-based metabolomics for Alzheimer’s disease early detection: targeted approaches versus untargeted approaches
Reveglia, P., Paolillo, C., Ferretti, G., Carlo, A. D., Angiolillo, A., Nasso, R., Caputo, M., Matrone, C., Costanzo, A. D., & Corso, G. (2021) · Metabolomics · doi:10.1007/s11306-021-01828-w · Cited by 40
Sex differences in cognitive aging: a 4-year longitudinal study in marmosets
Rothwell, E. S., Workman, K. P., Wang, D., & Agnès Lacreuse, A. (2021) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2021.09.015 · Cited by 37
Atypical Alzheimer Disease Variants
Polsinelli, A. J., & Apostolova, L. G. (2022) · Continuum · doi:10.1212/con.0000000000001082 · Cited by 39
GA-MADRID: design and validation of a machine learning tool for the diagnosis of Alzheimer’s disease and frontotemporal dementia using genetic algorithms
García‐Gutiérrez, F., Álvarez, J. D., Matías‐Guiu, J. A., Pytel, V., Matías‐Guiu, J., Cabrera‐Martín, M. N., & Ayala, J. L. (2022) · Medical & Biological Engineering & Computing · doi:10.1007/s11517-022-02630-z · Cited by 44
Coping strategies utilized by middle-aged and older latino caregivers of loved ones with Alzheimer’s disease and related dementia
Balbim, G. M., Marques, I. G., Cortez, C., Magallanes, M., Rocha, J., & Marquez, D. X. (2019) · Journal of Cross-Cultural Gerontology · doi:10.1007/s10823-019-09390-8 · Cited by 37
Design, synthesis, anti-acetylcholinesterase evaluation and molecular modelling studies of novel coumarin-chalcone hybrids
Hasan, A. H., Shakya, S., Hussain, F. H. S., Murugesan, S., Chander, S., Pratama, M. R. F., Jamil, S., Das, B., Biswas, S., & Jamalis, J. (2023) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2022.2162583 · Cited by 39
“Alzheimer’s disease (AD) is the most frequent form of dementia, characterised by a decline in intellectual ability, behavioural alteration, and impairment in daily living activities (McKhann et al., 2011; NA, 2019; Sivakumar et al., 2020).”
Background
AI-DrugNet: A network-based deep learning model for drug repurposing and combination therapy in neurological disorders
Pan, X., Yun, J., Coban‐Akdemir, Z., Jiang, X., Wu, E., Huang, J. H., Sahni, N., & Yi, S. S. (2023) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2023.02.004 · Cited by 36
Multimodal learning of clinically accessible tests to aid diagnosis of neurodegenerative disorders: a scoping review
Huang, G., Li, R., Bai, Q., & Alty, J. (2023) · Health Information Science and Systems · doi:10.1007/s13755-023-00231-0 · Cited by 40
Self-Supervised ASR Models and Features for Dysarthric and Elderly Speech Recognition
Hu, S., Xie, X., Geng, M., Jin, Z., Deng, J., Li, G., Wang, Y., Cui, M., Wang, T., Meng, H. M. L., et al. (2024) · IEEE/ACM Transactions on Audio Speech and Language Processing · doi:10.1109/taslp.2024.3422839 · Cited by 40
“Neurocognitive disorders, such as Alzheimer’s disease (AD), are often found among older adults and manifest themselves in speech and language impairments [15], [16].”
Background
Computational screening of promising beta-secretase 1 inhibitors through multi-step molecular docking and molecular dynamics simulations - Pharmacoinformatics approach
Gupta, S., Parihar, D., Shah, M., Yadav, S., Managori, H., Bhowmick, S., Patil, P. C., Alissa, S. A., Wabaidur, S. M., & Islam, M. A. (2019) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2019.127660 · Cited by 38
The effectiveness of interventions to improve the care and management of people with dementia in general hospitals: A systematic review
Feast, A. R., White, N., Candy, B., Kupeli, N., & Sampson, E. L. (2020) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.5280 · Cited by 38
If we knew then what we know now: The preparedness experience of pre-loss and post-loss dementia caregivers
Supiano, K. P., Luptak, M., Andersen, T. C., Beynon, C., Iacob, E., & Wong, B. G. (2020) · Death Studies · doi:10.1080/07481187.2020.1731014 · Cited by 38

Authors: Alzheimer's Association
Corresponding author: Alzheimer's Association
Venue: Alzheimer's & Dementia
Publisher: Wiley
Published: 2019-03
Volume: 15
Issue: 3
Pages: 321-387
ISSN: 1552-5260 (ISSN-L)
1552-5279
DOI: 10.1016/j.jalz.2019.01.010
OpenAlex: W4211139529
Cited by: 2,461
References: 496
Citations by year: 2026: 108 · 2025: 214 · 2024: 245 · 2023: 310 · 2022: 357 · 2021: 558 · 2020: 544 · 2019: 120
FWCI: 316.68
Type: journal article
Language: en
Open access: closed
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor)
Locations: Alzheimer s & Dementia (publishedVersion)
Topics: Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Health Sciences › Medicine › Geriatrics and Gerontology › Geriatric Care and Nursing Homes
Keywords: Alzheimer's disease, dementia

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

2019 Alzheimer’s disease facts and figures.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks